428 related articles for article (PubMed ID: 27325614)
21. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.
Thomas EG; Thomas DJ
Immunol Allergy Clin North Am; 2023 Aug; 43(3):553-568. PubMed ID: 37394259
[TBL] [Abstract][Full Text] [Related]
22. Pediatric Expression of Mast Cell Activation Disorders.
Broesby-Olsen S; Carter M; Kjaer HF; Mortz CG; Møller MB; Kristensen TK; Bindslev-Jensen C; Agertoft L
Immunol Allergy Clin North Am; 2018 Aug; 38(3):365-377. PubMed ID: 30007457
[TBL] [Abstract][Full Text] [Related]
23. Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis.
Brockow K; Plata-Nazar K; Lange M; Nedoszytko B; Niedoszytko M; Valent P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799959
[TBL] [Abstract][Full Text] [Related]
24. Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay.
Sargur R; Cowley D; Murng S; Wild G; Green K; Shrimpton A; Egner W
Clin Exp Immunol; 2011 Mar; 163(3):339-45. PubMed ID: 21303361
[TBL] [Abstract][Full Text] [Related]
25. Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome.
Giannetti MP; Akin C; Castells M
J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1196-1201. PubMed ID: 32276688
[TBL] [Abstract][Full Text] [Related]
26. Drug allergy in mast cell disease.
Brockow K; Bonadonna P
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):354-60. PubMed ID: 22744266
[TBL] [Abstract][Full Text] [Related]
27. Mast cell tryptase: a review of its physiology and clinical significance.
Payne V; Kam PC
Anaesthesia; 2004 Jul; 59(7):695-703. PubMed ID: 15200544
[TBL] [Abstract][Full Text] [Related]
28. Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock.
Casassa EA; Mailhol C; Tournier E; Laurent C; Degboe Y; Eischen M; Kirsten N; Moreau J; Evrard SM; Mansat-De Mas V; Lamant L; Dubreuil P; Apoil PA; Hermine O; Paul C; Bulai Livideanu C
Allergol Int; 2019 Jan; 68(1):119-121. PubMed ID: 30097253
[No Abstract] [Full Text] [Related]
29. Mastocytosis and allergy.
Greenhawt M; Akin C
Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):387-92. PubMed ID: 17873577
[TBL] [Abstract][Full Text] [Related]
30. Human mast cell tryptase in biology and medicine.
Vitte J
Mol Immunol; 2015 Jan; 63(1):18-24. PubMed ID: 24793463
[TBL] [Abstract][Full Text] [Related]
31. Idiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists.
Gulen T; Akin C
Curr Allergy Asthma Rep; 2021 Feb; 21(2):11. PubMed ID: 33560495
[TBL] [Abstract][Full Text] [Related]
32. The potential clinical utility of serum alpha-protryptase levels.
Kanthawatana S; Carias K; Arnaout R; Hu J; Irani AM; Schwartz LB
J Allergy Clin Immunol; 1999 Jun; 103(6):1092-9. PubMed ID: 10359891
[TBL] [Abstract][Full Text] [Related]
33. Fatal hymenoptera venom anaphylaxis by undetected clonal mast cell disorder: A better identification of high risk patients is needed.
Chatain C; Sedillot N; Thomas M; Pernollet M; Bocquet A; Boccon-Gibod I; Bouillet L; Leccia MT
Rev Med Interne; 2021 Dec; 42(12):869-874. PubMed ID: 34776279
[TBL] [Abstract][Full Text] [Related]
34. Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis.
Vitte J; Sabato V; Tacquard C; Garvey LH; Michel M; Mertes PM; Ebo DG; Schwartz LB; Castells MC
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):2994-3005. PubMed ID: 33746087
[TBL] [Abstract][Full Text] [Related]
35. Mast Cell Disorders In Drug Hypersensitivity.
Bonadonna P; Bonifacio M; Zanotti R
Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
[TBL] [Abstract][Full Text] [Related]
36. Risk assessment in anaphylaxis: current and future approaches.
Simons FE; Frew AJ; Ansotegui IJ; Bochner BS; Golden DB; Finkelman FD; Leung DY; Lotvall J; Marone G; Metcalfe DD; Müller U; Rosenwasser LJ; Sampson HA; Schwartz LB; van Hage M; Walls AF
J Allergy Clin Immunol; 2007 Jul; 120(1 Suppl):S2-24. PubMed ID: 17602945
[TBL] [Abstract][Full Text] [Related]
37. Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
Valent P; Akin C; Arock M
Curr Allergy Asthma Rep; 2024 Mar; 24(3):133-141. PubMed ID: 38308674
[TBL] [Abstract][Full Text] [Related]
38. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.
Schwartz LB; Sakai K; Bradford TR; Ren S; Zweiman B; Worobec AS; Metcalfe DD
J Clin Invest; 1995 Dec; 96(6):2702-10. PubMed ID: 8675637
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
González-de-Olano D; Navarro-Navarro P; Muñoz-González JI; Sánchez-Muñoz L; Henriques A; de-Andrés-Martín A; Peralta-Arjonilla D; Mayado A; Jara-Acevedo M; García-Montero AC; Orfao A; Álvarez-Twose I
Allergy; 2024 Mar; 79(3):711-723. PubMed ID: 37818990
[TBL] [Abstract][Full Text] [Related]
40. Stinging Hymenoptera and mastocytosis.
Ruëff F; Dugas-Breit S; Przybilla B
Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):338-42. PubMed ID: 19474708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
